Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04092192
Other study ID # IRB 18-1502
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 26, 2018
Est. completion date December 31, 2028

Study information

Verified date January 2024
Source University of Chicago
Contact Osmanuddin Ahmed, MD
Phone 773-795-7226
Email oahmed@uchicago.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

IVC filters are mechanical filters placed in a patient's body to trap blood clots in the legs migrating to the lungs. When no longer indicated, interventional radiologists are consulted for IVC filter removal. Currently, many methods for extracting IVC filters exist. Two of the most common methods involve using an endovascular snare device or rigid forceps. We intend to prospectively compare these two methods in an attempt to see if one offers an advantage to the other. This will be compared by evaluating success rates and procedure time.


Description:

Currently the optimal method for IVC filter retrieval with respect to success rate and fluoroscopic time (i.e. radiation exposure) is poorly understood. Both snare and forcep techniques have independently evaluated in literature but have never been compared directly. The proposed study would prospectively assess whether one of these established technique offers an advantage with respect to either of these variables.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 31, 2028
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Non-pregnant females - Adult patients (age 18 years and older) - Referred to Interventional Radiology for IVC filter removal - IVC filter implanted less than 6 months with the procedure being performed at UCMC by current IR staff. - Cook Celect filter or Argon Medical Option Elite Exclusion Criteria: - Patients with outside hospital filter placement - Filters other than Cook Celect or Argon Medical Option Elite - Implantation period >6 months - Evidence of coagulopathy (INR <1.8, platelet count >50k) - Clotting disorder - Central venous occlusion - Prior filter placement/removal.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
IVC filter removal
In the clinic, it will be explained to patient that they are asked to participate in a study that would randomize them to one of two established techniques for IVC filter removal. It will be explained these are both techniques that are used by interventional radiologists normally used for IVC filter retrieval. One technique would be the utilization of an endovascular snare (like a lasso) device that is designed to catch the hook of the filter and allow it to be captured. The other technique described will be the usage of a rigid forceps device that will be used to engage the filter apex directly and allow for the filter to be capture/removed.

Locations

Country Name City State
United States UChicago Medicine Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Removal success rate Data will be analyzed by a biostatistician to determine statistical differences between cohorts with respect to outcome measures. Procedure date
Primary Flouroscopy time Venography will be performed using a flush catheter and contrast material to evaluate for tip embedding. After filter retrieval, repeat venography will be performed to evaluate for thrombosis, caval spasm, caval perforation, fractured fragments, and other potential complications. Procedure start to finish
Primary Costs Costs associated with filter removal encounter Date of procedure up through 6 months following IVC filter removal
Primary Procedure related complications After hemostasis is achieved, patients will be monitored for 2-4 hours in the interventional radiology recovery area.
One month after filter retrieval, patients will be seen in clinic for follow-up. During this visit, a physicial assessment will done, including adverse events and review of medications.
Six months after filter retrieval, patient will be contacted by telephone for follow-up. Adverse event and medication review will be performed during this call.
Date of procedure through 6 months following IVC filter removal
See also
  Status Clinical Trial Phase
Recruiting NCT05003843 - BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis N/A
Recruiting NCT06239493 - IVUS-Guided Treatment for Percutaneous Vascular Interventions
Recruiting NCT05491109 - Soft Robotic Sock Intervention for Robot-assisted Ankle-foot Mobility in Post-stroke Patients N/A
Active, not recruiting NCT03575364 - ClotTriever Outcomes (CLOUT) Registry
Completed NCT04709120 - Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection
Completed NCT03943966 - In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer N/A
Completed NCT05264168 - Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data
Completed NCT02369263 - DVT Ultrasound in the Emergency Department N/A
Completed NCT04191928 - Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy Phase 1
Recruiting NCT04535128 - COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications
Completed NCT03443310 - Bedside Ultrasound by Anesthesiologists for Screening Deep Venous Thrombosis N/A
Completed NCT00253851 - Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery Phase 4
Completed NCT05226416 - Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection
Completed NCT02376803 - The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT Phase 4
Completed NCT05790317 - Comparison of the Effect of Traditional Method and Eras Protocol in Obesity Surgery N/A
Recruiting NCT04486859 - Postoperative Thrombosis Prevention in Patients With CD N/A
Suspended NCT01305148 - Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) N/A
Recruiting NCT00163956 - Failed Retrieval of Inferior Vena Cava (IVC) Filters: Long-Term Outcomes N/A